Your browser doesn't support javascript.
loading
CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy.
Drouin, Marion; Saenz, Javier; Gauttier, Vanessa; Evrard, Berangere; Teppaz, Geraldine; Pengam, Sabrina; Mary, Caroline; Desselle, Ariane; Thepenier, Virginie; Wilhelm, Emmanuelle; Merieau, Emmanuel; Ligeron, Camille; Girault, Isabelle; Lopez, Maria-Dolores; Fourgeux, Cynthia; Sinha, Debajyoti; Baccelli, Irene; Moreau, Aurelie; Louvet, Cedric; Josien, Regis; Poschmann, Jeremie; Poirier, Nicolas; Chiffoleau, Elise.
Affiliation
  • Drouin M; OSE Immunotherapeutics, Nantes, France.
  • Saenz J; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Gauttier V; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Evrard B; OSE Immunotherapeutics, Nantes, France.
  • Teppaz G; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Pengam S; OSE Immunotherapeutics, Nantes, France.
  • Mary C; OSE Immunotherapeutics, Nantes, France.
  • Desselle A; OSE Immunotherapeutics, Nantes, France.
  • Thepenier V; OSE Immunotherapeutics, Nantes, France.
  • Wilhelm E; OSE Immunotherapeutics, Nantes, France.
  • Merieau E; OSE Immunotherapeutics, Nantes, France.
  • Ligeron C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Girault I; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Lopez MD; OSE Immunotherapeutics, Nantes, France.
  • Fourgeux C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Sinha D; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Baccelli I; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Moreau A; OSE Immunotherapeutics, Nantes, France.
  • Louvet C; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Josien R; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Poschmann J; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
  • Poirier N; CHU Nantes, Nantes Université, Laboratoire d'Immunologie, CIMNA, Nantes, France.
  • Chiffoleau E; Nantes Université, INSERM, CHU Nantes, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France.
Sci Adv ; 8(46): eabo7621, 2022 11 16.
Article de En | MEDLINE | ID: mdl-36399563
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cross-priming / Tumeurs Limites: Animals Langue: En Journal: Sci Adv Année: 2022 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cross-priming / Tumeurs Limites: Animals Langue: En Journal: Sci Adv Année: 2022 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique